Leading bioscience company Biomega’s biorefinery is nearing completion. The facility, which is based in Hirstshals in Denmark, follows on from a successful upgrade of their flagship site, based near Bergen, in Norway.
Biomega specialises in high-quality ingredients for the animal and human health and nutrition markets. Its biorefinery in Norway produces hydrolysed salmon proteins, salmon meal and salmon oil for use in these markets. By transferring salmon offcuts into food and feed products via the biorefining process, the company is working towards a circular economy, as well as collaborating with local suppliers of fresh salmon long-term.
As production equipment is being delivered and assembled at the site, biomega are also working towards establishing a power supply, being on track to complete the facility in time. As Denmark transitions towards becoming a 100 percent self-sufficient nation with regards to gas supply, 30 percent of gas used in the region comes from biogas.
To be “in line with this objective,” the company explained in a press release, gas installed on site at Hirtshals is sourced from a Danish distribution network. It added that they will be collaborating with Greenport North, energy supplier, for the production and use of green energy.
The new facility will extend biomega’s capacity by a minimum of 20,000 tonnes of raw materials, to support growth in human and petfood applications. As it is located near stock supply, it provides an important gateway for salmon into Europe.
Expanding its current production capacity supports long-term plans to grow the new salmon peptide range for human health and nutrition, as well as the Salmigo range designed for premium petfood. The Salmigo product range contains about 90 percent proteins (peptides and free amino acids), and provides a digestible, sustainable and nutritional source of protein.
For more information on biomega visit their website, HERE.
